Spectral-domain Optical Coherence Tomography Retinal and Choroidal Thickness Metric Repeatability in Age-related Macular Degeneration

被引:14
作者
Hanumunthadu, Daren [1 ,2 ]
Ilginis, Tomas [1 ,2 ]
Restori, Marie [1 ,2 ]
Sagoo, Mandeep [1 ,2 ]
Tufail, Adnan [1 ,2 ]
Balaggan, Kamaljit S. [1 ,2 ]
Patel, Praveen J. [1 ,2 ]
机构
[1] Moorfields Eye Hosp Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr, London, England
[2] UCL, Inst Ophthalmol, London, England
关键词
INTRAVITREAL AFLIBERCEPT; SEGMENTATION ERROR; BLOOD-FLOW; THERAPY; REPRODUCIBILITY; BEVACIZUMAB; PARAMETERS; VOLUME; EYES; OCT;
D O I
10.1016/j.ajo.2016.03.052
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To determine the intrasession repeatability of spectral-domain OCT (SDOCT)-derived macular retinal and choroidal metrics in patients with neovascular age-related macular degeneration (nAMD) in the Distance of Choroid Study (DOCS). DESIGN: Validity and reliability analysis. METHODS: Enrolled patients underwent repeated SDOCT imaging using the Spectralis OCT (Heidelberg Engineering, Heidelberg, Germany). A single technician certified for clinical trials took 3 macular volume scans. Retinal thicknesses were calculated for each of the 9 Early Treatment Diabetic Retinopathy Study (ETDRS) macular subfields. Center point thickness and total macular volume were also included in the analysis. Manual subfoveal choroidal thickness measurements were made by a masked observer. RESULTS: A total of 40 eyes of 40 patients were included in this analysis (mean [+/- standard deviation] age: 74.1 [+/- 7.2] years, 60% male). The coefficient of repeatability (CR) of the central macular subfield was 30.6 mu m (95% confidence interval [CI] 29.8-1.4 mu m). The CR for the other macular subfields ranged from 7.0 mu m to 38.2 mu m. The CR for the total macular volume was 0.212 mm(3) (95% CI 0.206-0.217 mm(3)) and the CR for the center point was 47.5 mu m (95% CI 46.2-48.7 mu m). Images were also reviewed for the presence of segmentation error in the central macular subfield, and after exclusion of these eyes the revised CR for this subfield was 13.7 mu m (95% CI 13.3-14.1 mu m). The intrasession CR of subfoveal choroidal thickness was 34.7 mu m (95% CI 33.7-35.7 mu m). CONCLUSIONS: This study suggests that a change of greater than 31 mu m in Spectralis SDOCT-derived retinal thickness measurement of the central macular subfield and 35 mu m in subfoveal choroidal thickness is necessary to detect true clinical change associated with disease progression or improvement in nAMD with a revised figure of 14 mu m for central macular retinal subfield thickness in the absence of segmentation error. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:154 / 161
页数:8
相关论文
共 32 条
  • [1] STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
    BLAND, JM
    ALTMAN, DG
    [J]. LANCET, 1986, 1 (8476) : 307 - 310
  • [2] Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
    Chakravarthy, Usha
    Harding, Simon P.
    Rogers, Chris A.
    Downes, Susan M.
    Lotery, Andrew J.
    Wordsworth, Sarah
    Reeves, Barnaby C.
    [J]. OPHTHALMOLOGY, 2012, 119 (07) : 1399 - 1411
  • [3] Choroidal Thickness in Polypoidal Choroidal Vasculopathy and Exudative Age-related Macular Degeneration
    Chung, Song Ee
    Kang, Se Woong
    Lee, Jung Hye
    Kim, Yun Taek
    [J]. OPHTHALMOLOGY, 2011, 118 (05) : 840 - 845
  • [4] Repeatability of Spectralis OCT Measurements of Macular Thickness and Volume in Diabetic Macular Edema
    Comyn, Oliver
    Heng, Ling Zhi
    Ikeji, Felicia
    Bibi, Kanom
    Hykin, Philip G.
    Bainbridge, James W.
    Patel, Praveen J.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (12) : 7754 - 7759
  • [5] Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography
    de Boer, JF
    Cense, B
    Park, BH
    Pierce, MC
    Tearney, GJ
    Bouma, BE
    [J]. OPTICS LETTERS, 2003, 28 (21) : 2067 - 2069
  • [6] Gallego-Pinazo Roberto, 2014, Med Hypothesis Discov Innov Ophthalmol, V3, P111
  • [7] Visual and anatomical outcomes following intravitreal aflibercept in eyes with recalcitrant neovascular age-related macular degeneration: 12-month results
    Grewal, D. S.
    Gill, M. K.
    Sarezky, D.
    Lyon, A. T.
    Mirza, R. G.
    [J]. EYE, 2014, 28 (07) : 895 - 899
  • [8] Grunwald JE, 1998, INVEST OPHTH VIS SCI, V39, P385
  • [9] Reduced foveolar choroidal blood flow in eyes with increasing AMD severity
    Grunwald, JE
    Metelitsina, TI
    DuPont, JC
    Ying, GS
    Maguire, MG
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (03) : 1033 - 1038
  • [10] Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
    Heier, Jeffrey S.
    Brown, David M.
    Chong, Victor
    Korobelnik, Jean-Francois
    Kaiser, Peter K.
    Quan Dong Nguyen
    Kirchhof, Bernd
    Ho, Allen
    Ogura, Yuichiro
    Yancopoulos, George D.
    Stahl, Neil
    Vitti, Robert
    Berliner, Alyson J.
    Soo, Yuhwen
    Anderesi, Majid
    Groetzbach, Georg
    Sommerauer, Bernd
    Sandbrink, Rupert
    Simader, Christian
    Schmidt-Erfurth, Ursula
    [J]. OPHTHALMOLOGY, 2012, 119 (12) : 2537 - 2548